Stargardt ta cuta: description, Yanã, cututtuka da kuma magani siffofin

Stargardt ta cuta ne degenerative tsari tsokani a macula. Akwai da yawa cututtuka asibitin wanda yake kama da wannan Pathology. Suna sa ta maye gurbi na daban-daban kwayoyin halittu. Saboda haka, cutar nasa ne da category na hereditary pathologies.

Babban asibiti bayyanuwar da cuta ne a degenerative tsari a cikin macula da kuma tsakiyar retinitis pigment haddasa drop of ci gaban a tsakiyar scotoma.

Features da cutar

Stargardt ta cuta ne m amma sosai tsanani pathologies. Yana bayyana kanta a wani matasa shekaru - daga 6 zuwa 20 shekaru da mita na 1: 20,000. A wasu shekaru Categories Pathology, kamar yadda mai mulkin, ba vstrechvaetsya. A sakamakon catastrophic cututtuka. Ba zai yi jinyar cikakken asarar hangen nesa.

A cuta yana da wani kayyade akai. Dystrophic aiwatar rinjayar retinal macular yankin da kuma fãra a pigment epithelium, wadda take kaiwa zuwa asarar gani. A tsari ne na juna.

pathological fom

Akwai bayyana rabo daga Pathology cikin hudu iri dangane da yankin na kumburi sarrafawa:

Degenerative tsari za a iya lura:

• a tsakiyar gefe zone.
• a cikin macular yankin.
• a cikin paracentral zone.

Har ila yau, akwai wani gauraye nau'i na cutar da cewa ya shafi kumburi sarrafa a cikin tsakiyar ɓangare na ido da kuma a kan periphery.

Sassan cuta ci gaba

A Sanadin cutar da aka bayyana likita Karl Stargardt a farkon rabin karni na ashirin da. A masa mutunci kuma suna da cutar. A Pathology aka alaka da macular yankin da kuma, bisa ga masanin kimiyya, an canja shi a cikin wani iyali gādo. Yawancin lokaci kaddamarda polymorphic ophthalmoscopic hoto, wanda ake kira da sunan "atrophy na da choroid," "bijimin ido", "karye tagulla", da sauransu.

Ta hanyar positional cloning master gene wuri da aka gano da cewa yana sa retinitis pigmentosa, shi ne mafi bayyanannu a cikin photoreceptors. A kimiyya shi ne ake kira ABCR.

Eye cuta da aka gada a wani autosomal rinjaye hanya. Domin pathologies halin da sarrafawa da mutated genes a chromosomes 13q da 6ql4.

A kayyade akai ba bisa jinsi. A cewar 'yan karatu na doctor- jini, tare da rinjaye irin watsa daga cikin cuta, yana daukan kadan sauki, kuma ba ko da yaushe kai ga makanta. Mai cell rabe ci gaba da aiki. A cikin wadannan marasa lafiya, da Pathology faruwa a tare da kadan bayyanar cututtuka. Shafi rike aiki da kuma yiwuwar tuki motocin.

Ta yaya ne Stargardt ta cuta? A Sanadin macular degeneration da Kwayoyin kwanta a rashin makamashi. Gene aibi tsokani samar da wani m gina jiki wanda Canza wurin ATP kwayoyin ta hanyar da jikin tantanin macular tsakiyar ɓangare na akan tantanin ido. Yana mayar da hankali image graphics da kuma launi.

symptomatology Pathology

Mene ne halaye na mutane da Stargardt ta cuta? Tare da ci gaban da cutar Pathology ba lura a sauran kayan ciki. A tsari rinjayar kawai idanu. Haka kuma cutar ta fara da wata hasara na gani acuity. Daga baya bayyanar cututtuka suna karuwa ne, kuma akwai babban take hakki na ji na launi a duk faɗin gane ra'ayi na na zangon.

Degenerative canje-canje na fundus aka nuna a cikin wadannan Figures:

• a duka idanu alama pigmented madauwari dot siffar.
• akwai na gida yankunan bã tãre da pigment.
• ya lura atrophic tsari a cikin retinal pigment epithelium.

Irin wannan matakai na iya faruwa a tare da tare da ya faru na whitish-yellow spots. Kamar yadda cutar progresses a retinal pigment epithelium saukar da karin jari na lipofuscin-kamar abu.

Dukan marasa lafiya shafi wannan Pathology, gano cikakkar ko m tsakiyar scotoma, wanda da daban-daban dabi'u, saboda da ruwan dare daga cikin tsari.

Lokacin da zheltopyatnistoy siffa akwatin na wani mutum haƙuri iya zama a cikin al'ada iyaka, amma tsakiyar gani ya markedly rage.

Mafi yawan lokuta mutanen da suka halartar binciken, an lura da wani take hakkin da fahimta da launuka deuteranopia type, ja-kore diskhromazii. Lokacin da zheltopyatnistom dystrophic aiwatar da launi hangen nesa iya zama gaba daya unaffected.

Dystrophy Stargardt shigarsu wani canji a cikin sarari mita bambanci ji na ƙwarai (a aiwatar manzilõli, 6 - 10 º da gagarumin raguwa a yankin na tsakiya na sarari mitoci, kuma a cikin cikakken rashi na high mita yankin). A ciwo ne ake kira "kwaikwaya daga mazugi dystrophy."

Alamun sun hada da wavy wahayin kõme, makafi spots, blurriness, launi da kuma take hakkin karbuwa wahala a gaban rage haske.

cuta ganewar asali

A sakamakon bincike a kayyade matakin an saukar shaida cewa ido cuta Stargardt m allelic cuta wuri ABCR.

Ganewar asali da cutar ta fara da wani bincike na jihar na fundus. Yi fluorescein angiography na retinal jijiyoyin bugun gini da electrophysiological jarrabawa. A wannan yanayin, ya tabbatar da dalilin da mataki na lalacewa ake bukata. Wannan ya sa ya yiwu don gane da yawan cutar Manuniya, ciki har da giperflyuorestsiruyuschie Aljihuna da kuma haske na na gani jijiya.

Tun da cutar ne hereditary yanayi, mafi m hanya kayyade wannan ganewar asali zai zama a DNA, wanda yake iya tantance hereditary cututtuka monomonogennye.

bambanci ganewar asali

Stargardt ta cuta ya zama mai rabuwa da mazugi-sanda-da, daga mazugi, kuma Wand-na mazugi dystrophy, m foveal dystrophy, rinjaye, na yara Retinoschisis, macular dystrophy vitelliformnoy.

Har ila yau, bambanci ganewar asali da aka nuna a cikin hali na ciki toxemia samu saboda sashi degeneration (musamman, a lokacin da hlorokvinovoy retinopathy).

Za a iya warke Stargardt ta cuta?

Etiologic far ba ya wanzu. Yana gusar da Stargardt ta cuta? karin hali Jiyya shafi yin amfani da parabulbar allura taurine kuma antioxidants gabatarwar nufin mikawa receptacles (pentoxifylline, nicotinic acid), da kuma steroids.

Untreated bitamin da inganta jirgin ruwa bango da kuma inganta jini wurare dabam dabam. bitamin amfani B, A, C, E.

An nuna rike da physiotherapy. Daga cikin su ya kamata mu haskaka electrophoresis yin amfani da kwayoyi, da kuma retinal ruri da Laser.

Aiyuka revasulyarizatsiya akan tantanin ido ta dasawa tare da macular yanki tsoka zaruruwa.

A baya can ophthalmologists duniya yi imani da cewa cutar ba daman a. A bisa hanyoyin kwantar da hankali taimaka kawai dan kadan jinkirta da ci gaban da cutar, amma a wani hali kada ku hana shi.

Matsayin mai mulkin, da magani bai ceci mutane daga cikakken asarar hangen nesa. Ake bukata wajen samar da wata hanya da cewa zai sauƙaƙe sabuntawa na lalace ocular Tsarin.

The m dabara na far

Shin, akwai a halin yanzu wani tasiri Hanyar domin kau da irin wannan Pathology kamar yadda Stargardt ta cuta? Yadda za mu bi rashin lafiya mai tsanani? A Hanyar da aka samarwa a shekara ta 2009 da Dr. Aleksandrom Dmitrievichem Romaschenko, wanda shi ne shugaban da Ophthalmology Center "ON Clinic" (Saint-Petersburg, ul. Marata, gidan 69, da gina B). Da suka inganta cuta magani wani zaɓi dogara ne a kan salula nama magani.

Dalili na magani ne aikace-aikace na kara Kwayoyin na adipose nama da waxannan cututtukan da mutum. A warkewa Hanyar da aka ɓullo da masana kimiyya a baya VP Filatov. Godiya ga m fasahar da marasa lafiya suna ba da damar mayar da rasa hangen nesa da kuma samar da wani cikakken rai.

Dr. AD aka rajista Romashchenko hadaddun ilimin halittu da aikin likita da fasaha da kuma jadadda mallaka da wadannan hanyoyin da kara cell jiyya :

• a hade Hanyar cire rigar nau'i na cutar.
• hadaddun Hanyar paitogeneticheskogo far cibiyar da tapetoretinalnoy dystrophy.

A daya asibitin ne magani?

A lura da hadaddun cututtuka ya kasance ophthalmologic cibiyar "A Clinic". A cibiyar aka located a wani gari kamar St. Petersburg. Bi da Stargardt ta cuta iya zama a cibiyar, tun da shi ne kawai daya a Rasha, inda irin fasahar ne amfani.

Shin kara cell far ne hadari?

Ma'aikata iya amincewa tabbatar da cewa fasahar far raya AD Romashchenko, shi ne cikakken lafiya. Domin lura da haƙuri da Kwayoyin suna amfani, abin da gusar da yiwuwar kin amincewa ko wasu mummunan sakamakon.

ƙarshe

Shtargradta cuta halarta a karon a farkon shekarun da sauri kai zuwa wani cikakken asarar hangen nesa. A sosai rare lokuta, gādon rinjaye type, ido saukad da sannu a hankali. Marasa lafiya rika ziyarci wani ophthalmologist, bitamin da kuma saka tabarau. A mafi tasiri hanyar kawar da Pathology dauke far ta kara Kwayoyin.